forming the theoretical basis for many of the acute stroke therapies under study (Lees et al., 2006) as well as the rationale for intervening within a therapeutic time window following ischemic ...
The clot-dissolving medication, alteplase, improved stroke patients' recovery by more than 50% when given up to 24 hours ...
A new advisory from the American Heart Association strongly endorses endovascular treatment for patients with large core ...
11don MSN
The University of Cincinnati's Pooja Khatri spoke with Medscape on a new American Heart Association advisory recommending ...
DiaMedica's DM199 shows promise for Acute Ischemic Stroke, but caution is advised due to low market cap and trial outcome uncertainties. See more on DMAC here.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback